ナトリウム−グルコース共輸送体阻害薬の新規な結晶形及びその製造方法並びに用途 - Crystal Pharmaceuticals (Sucho) Company, Limited

Title:

ナトリウム−グルコース共輸送体阻害薬の新規な結晶形及びその製造方法並びに用途

Document Type and Number:

Japanese Patent JP6727419

Kind Code:

B2

Abstract:

The present disclosure relates to novel crystalline forms of a sodium-glucose co-transporter inhibitor drug (Sotagliflozin), processes for preparation and use thereof. The present disclosure also relates to pharmaceutical composition comprises novel crystalline forms of Sotagliflozin and use of novel crystalline forms and pharmaceutical composition of Sotagliflozin for preparing drugs for treating diseases. The crystalline forms provided by the present disclosure have advantages of good stability, relatively low hygroscopicity, suitability for process development and post-treatment, simple processes for preparation, low cost, and has significant value for future drug optimization and development.

More Like This:

JP2005538032	Fluorescent natural pigments derived from marine organisms
JP2021506962	Synthesis of 1: 1: 1 co-crystal consisting of 1-cyano-2- (4-cyclopropyl-benzyl) -4- (β-D-glucopyranos-1-yl) -benzene, L-proline and water
WO/2020/040433	METHOD FOR PREPARATION OF SGLT-2 INHIBITOR, DAPAGLIFLOZIN PRECURSOR

Inventors:

Chen, Minhua
Jahn, Janphen
Elephant, poe
Riu, Kai
Shaoyu

Application Number:

JP2019514170A

Publication Date:

July 22, 2020

Filing Date:

May 25, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Crystal Pharmaceuticals (Sucho) Company, Limited

International Classes:

C07H7/04; A61K31/70; A61P3/10

Domestic Patent References:

JP2011528366A
JP2010534661A
JP2010504998A

Attorney, Agent or Firm:

Shinjiro Ono
Osamu Yamamoto
Toru Miyamae
Motoharu Nakanishi
Akiko Yamaguchi

Previous Patent: 空調室内機

Next Patent: 空気調和装置